Oslo Pensjonsforsikring’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$444K Buy
712
+86
+14% +$58.5K 0.05% 134
2026
Q1
$484K Buy
+626
New +$479K 0.08% 106

Other funds holding REGN

Oslo Pensjonsforsikring's REGN Position: Q2 2026 in Review

Oslo Pensjonsforsikring increased its Regeneron Pharmaceuticals (REGN) stake by 14% in Q2 2026, buying an estimated $58.5K and bringing the position to 712 shares worth $444K. The position accounts for 0.05% of the portfolio, ranked #134.

Oslo Pensjonsforsikring first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $484K in Q1 2026. 1,328 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Oslo Pensjonsforsikring held 712 shares of Regeneron Pharmaceuticals worth $444K as of Q2 2026.
  • Oslo Pensjonsforsikring bought 86 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $58.5K.
  • Regeneron Pharmaceuticals made up 0.05% of Oslo Pensjonsforsikring's portfolio in Q2 2026, its #134 holding.
  • Oslo Pensjonsforsikring first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Oslo Pensjonsforsikring's Regeneron Pharmaceuticals position peaked at $484K in Q1 2026.
  • 1,328 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Oslo Pensjonsforsikring's 13F filing for Q2 2026, filed 31 Jul 2026.